| Stephen W Barker, DO | |
|
500 Vincent St, Stevens Point, WI 54481-1848 | |
| (715) 341-7920 | |
| (715) 341-0776 |
| Full Name | Stephen W Barker |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 500 Vincent St, Stevens Point, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265450357 | NPI | - | NPPES |
| 30051000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 32078 021 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen W Barker, DO Po Box 326, Stevens Point, WI 54481-0326 Ph: (715) 341-7920 | Stephen W Barker, DO 500 Vincent St, Stevens Point, WI 54481-1848 Ph: (715) 341-7920 |
News Archive
Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.
Lack of health insurance and financial worries about the cost of care contributed to as much as a six-hour delay in seeking emergency care for a heart attack, according to a first-of-its kind study published April 14 in the Journal of the American Medical Association.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
One out of three patients with asthma or chronic obstructive pulmonary disease (COPD) use their inhalers incorrectly, a new study shows.
A long non-coding RNA (lncRNA) regulates programmed cell death during one of the final stages of red blood cell differentiation, according to Whitehead Institute researchers. This is the first time a lncRNA has been found to play a role in red blood cell development and the first time a lncRNA has been shown to affect programmed cell death.
› Verified 7 days ago
Augusto M Alinea, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 Vincent St, Stevens Point, WI 54481 Phone: 715-341-7920 Fax: 715-341-0776 | |
Todd D Storch, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 Vincent St, Stevens Point, WI 54481 Phone: 715-341-7920 Fax: 715-341-0776 | |
Gary A Olson, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 900 Illinois Ave, Stevens Point, WI 54481 Phone: 715-341-7920 Fax: 715-341-0776 | |
Thomas J Wenman, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 Vincent St, Stevens Point, WI 54481 Phone: 715-341-7920 Fax: 715-341-0776 | |
Joanne L Heins, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Illinois Ave, Stevens Point, WI 54481 Phone: 715-346-5000 | |
Brett Joseph Longlais, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Illinois Ave, Stevens Point, WI 54481 Phone: 715-346-5000 |